Chemed Corporation $CHE Shares Bought by Intech Investment Management LLC

Intech Investment Management LLC grew its holdings in shares of Chemed Corporation (NYSE:CHE) by 73.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,522 shares of the company’s stock after purchasing an additional 2,330 shares during the period. Intech Investment Management LLC’s holdings in Chemed were worth $2,363,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CHE. Kestra Investment Management LLC grew its holdings in shares of Chemed by 64.7% in the 4th quarter. Kestra Investment Management LLC now owns 3,007 shares of the company’s stock worth $1,287,000 after acquiring an additional 1,181 shares during the period. Eukles Asset Management grew its holdings in shares of Chemed by 0.4% in the 4th quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock worth $2,591,000 after acquiring an additional 25 shares during the period. Hantz Financial Services Inc. grew its holdings in shares of Chemed by 32.9% in the 4th quarter. Hantz Financial Services Inc. now owns 323 shares of the company’s stock worth $138,000 after acquiring an additional 80 shares during the period. EverSource Wealth Advisors LLC grew its holdings in shares of Chemed by 27.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 371 shares of the company’s stock worth $159,000 after acquiring an additional 80 shares during the period. Finally, Legato Capital Management LLC acquired a new stake in shares of Chemed in the 4th quarter worth approximately $691,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on CHE shares. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen upgraded Chemed from a “hold” rating to a “buy” rating in a report on Sunday. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Royal Bank Of Canada upped their price target on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Finally, Oppenheimer lowered their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $501.50.

Chemed Price Performance

Shares of NYSE:CHE opened at $427.04 on Thursday. The business’s fifty day moving average price is $406.89 and its two-hundred day moving average price is $424.47. The stock has a market cap of $5.67 billion, a PE ratio of 23.27, a price-to-earnings-growth ratio of 1.56 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. Chemed Corporation has a one year low of $365.20 and a one year high of $569.98.

Chemed (NYSE:CHE) last announced its earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. The firm had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.Chemed’s quarterly revenue was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, analysts forecast that Chemed Corporation will post 22.3 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Thursday, May 28th. Chemed’s dividend payout ratio is 13.08%.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 3.33% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.